Vascular Injury Treatment Market

SKU: DM2589 | Last Updated On: Sep 16 2022 | Available Formats

> Vascular Injury Treatment Market is Expected to reach a high CAGR of 6.2% By 2029: DataM Intelligence

Vascular Injury Treatment Market is segmented By Injury (Thrombosis, Contusion/Intimal Flap, Laceration/Transection, Spasm, Aneurysm and Pseudoaneurysm, Arteriovenous (AV) Fistula, Others), By Treatment Methods (Patch Angioplasty, Lateral Arteriorrhaphy/ Venorrhaphy, Bypass Graft, Thrombectomy, Extraanatomic Bypass, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2022-2029


Vascular Injury Treatment Market size was valued at US$ 3.04 billion in 2021 and is estimated to reach US$ 5.05 million by 2029, growing at a CAGR of 6.2% during the forecast period (2022-2029).

Vascular Injury Treatment Market Report Scope:





Segments Covered

By Injury, By Treatment Methods, and By Region

Report Insights Covered

Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.

Regions Analyzed

North America, Latin America, Europe, Middle East, Africa, Asia Pacific, and the Rest of the world.

Major Companies Covered

Abbott Laboratories, EKF Diagnostics Holdings plc, BioMérieux SA, Atlas Medical, Quidel Corporation, BIOSYNEX SA, Prestige Brands Holdings, Swiss Precision Diagnostics (SPD) GmbH, Piramal Enterprises, NG BIOTECH SAS, and among the major companies listed in the final report.

To know more insights into the Diagnostic Imaging Market, get our Sample Brochure

Vascular injury happens when a blood artery is damaged (artery and veins). In addition, vascular surgeons identify these injuries according to the type of wound that caused them, such as a blunt or penetrating injury. A blunt injury happens when a blood vessel is squeezed or crushed, while a penetrating injury occurs when a blood vessel is punctured, torn, or severed. Furthermore, a blunt or penetrating injury may result in a life-threatening hemorrhage. Blood clots can be severe if they break off and migrate to other areas of the body, such as the lungs and brain, resulting in ischemic strokes and pulmonary embolism. The most frequent cause of peripheral artery injury is blunt or penetrating damage to the extremities. These injuries, which damage the main arteries, nerves, and veins, may have negative impacts if they are not identified and handled immediately, leading to long-term injury and deformity.

Market Dynamics

The global vascular injury treatment market growth driven by certain factors such by the number of vascular injuries increases, so does the need for vascular injury care. When the number of traffic collisions, crime, and injuries increases, so does the incidence of vascular injury damage, providing a demand for vascular injury care. State support for innovation and the healthcare industry has been expanded, which has aided business expansion.

Partnerships between major healthcare providers, is expected to drive the global vascular injury treatment market during the forecast period

Owing to an increase in hospital partnerships to provide clinical treatments for heart-associated disorders, the global vascular injury care market is projected to expand significantly over the forecast period. For example, Mayo Clinic Health System and OU Children's Hospital partnered on rare heart disease research in 2019. (Hypoplastic Left Heart Syndrome). Furthermore, they are working with a wide number of hospitals around the world to combat rare heart disease. Furthermore, Mayo Clinic, Children's Hospital of Philadelphia, Children's Hospital of Los Angeles, Children's Minnesota, and Children's Hospital Colorado partnered with five other Hypoplastic Left Heart Syndrome (HLHS) Consortium participants, including Mayo Clinic, Children's Hospital of Philadelphia, Children's Hospital of Los Angeles, Children's Minnesota, and Children's Hospital Colorado. Mayo Clinic Health System has collaborated with Eko in 2018 to develop data-driven technologies that would assist doctors in identifying potentially risky heart diseases. Eko and Mayo Clinic have also announced plans to build and commercialize a machine-based algorithm that will assist in the diagnosis of low ejection fraction in patients (a weak heart pump). As a result, the global vascular injury treatment market is projected to expand at a faster pace over the forecast period as more new technology for detecting heart disease is launched. According to the World Health Organisation, 17.9 million people die each year from cardiovascular disease. As a result, one of the reasons projected to fuel growth in the global vascular injury care market over the forecast period is the growing prevalence of cardiovascular disease.

High cost associated with vascular treatment hampering the growth of the vascular injury treatment market

However, one of the main reasons projected to hinder the development of the global vascular injury care industry is the high cost associated with vascular disease treatment. For eg, the total cost of non-coronary procedures linked to peripheral artery disease (PAD) is US$ 729. Furthermore, the average cost of antihypertensive treatment is USD 313, while the average cost of lipid-lowering therapy is USD 207. Furthermore, according to the American Heart Association (AHA), the overall cost of cardiovascular care in the U.S. is expected to exceed USD 1.1 trillion by 2035.

Industry Analysis

The global vascular injury treatment market provides in-depth analysis of the market based on various industry factors such as porter’s five force analysis, supply chain analysis, regulatory analysis, pricing analysis, reimbursement analysis, unmet needs and patent trends etc.

Segment Analysis

The bypass graft segment is expected to grow at the fastest CAGR during the forecast period (2022-2029) 

The bypass graft segment continues significant dominance due to features such as elevated occurrence rates and health problems associated with vascular diseases. The most serious vascular diseases include stroke, arteriovenous malformation (AVM), peripheral artery disease (PAD), carotid artery disease (CAD), abdominal aortic aneurysm (AAA), pulmonary embolism, critical limb ischemia (CLI), deep vein thrombosis (DVT), varicose veins, and chronic venous insufficiency (CVI). According to the National Institutes of Health (NIH), coronary heart disease affects approximately 14 million men and women in the United States. It is most prominent in people over the age of 65. Plaque, a waxy material that accumulates blood to the heart muscle inside the lungs, induces the condition. The most effective treatment for artery damage is a bypass graft to enhance poor blood supply to the heart. Individuals with obstructive coronary artery disease, a type of ischemic heart disease, can benefit from this surgery because it decreases the risk of serious complications. As a result, demand for bypass grafts is growing, propelling market growth over the projected period.

Geographical Analysis

North America region holds the largest market share of the global vascular injury treatment market

Throughout the forecast period, North America is anticipated to continue its dominance in the overall vascular injury treatment market. During the forecast period, the growing prevalence of vascular diseases is projected to be the major factor driving the market's overall growth. Furthermore, the geriatric population in the United States is increasing, which is expected to increase the demand for peripheral vascular care in the region. According to the Centers for Disease Control and Prevention (CDC), about 8.5 million individuals in the United States suffer from peripheral artery disease, with 12 percent -20 percent of those above the age of 60 suffering from the disease. These are also some of the major reasons maintaining the region's dominance.

Competitive Landscape

The vascular injury treatment market is moderately competitive, owing to the presence of major market players in the key regions such as US, China, India and others. The key vascular injury treatment players which are contributing to the growth of the global market include Cleveland Clinic, Massachusetts General Hospital, Heidelberg University Hospital, Royal Berkshire NHS Foundation Trust, Mayo Clinic Health System, Tenet Healthcare, Apollo Hospitals Enterprise Ltd., Universal Health Services, Inc., Mediclinic International, CHSPSC, LLC among others.

Global Vascular Injury Treatment Market – Key Companies to Watch

Cleveland Clinic

Overview: Cleveland Clinic is a Cleveland, Ohio-based nonprofit clinical medical center. The Cleveland Clinic Foundation, a non-profit group founded in 1921 in Ohio, maintains and manages a 170-acre (69-hectare) complex in Cleveland, as well as 11 associated hospitals, 19 family health centers in Northeast Ohio, and hospitals in Florida and Nevada. Cleveland Clinic also runs two Cleveland Clinic Canada locations in Toronto and the Cleveland Clinic Abu Dhabi hospital outside of the United States.

Product Portfolio: Endovascular aneurysm repair (EVAR)- It is a minimally invasive aneurysm repair surgery. A surgeon makes a small incision in your groin and inserts a catheter (thin, flexible tube) into an artery.

The global Vascular Injury Treatment market report would provide an access to an approx. 40+ market data table, 45+ figures and 180 pages

Trending Topics

Acute Lung Injury Market

Traumatic Brain Injury Therapeutics Market

Visual Imaging Market 

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report

Note*: For "Bundle/Bulk" Subscription of Reports,
please contact: [email protected]

Get your free sample proposal with a single click!